Abstract
Forty-three operative procedures were performed on a population of 250 patients with myeloproliferative disorders, including polycythemia vera, myeloid metaplasia (MM) and chronic myelogenous leukemia (CML). The overall operative mortality was approximately 7% and the incidence of excessive bleeding which could be related to coagulopathy was 5%. Twenty-one patients with MM or CML underwent splenectomy for palliation of symptoms related to the enlarged spleen or hematologic problems. Eighty-four percent of the latter group were improved. Adverse hematologic effects which could be attributed to splenectomy in these patients were confined to two patients who developed marked thrombocytosis. Among the 23 patients with MM, 9 had portal hypertension. Three underwent portacaval shunt and one a splenorenal shunt for bleeding varices. One of the patients died of hepatic necrosis. Estimated hepatic blood flow determinations (EHBF) in 4 patients with portal hypertension demonstrated a marked absolute increase and an increase in the ratio of EHBF/Cardiac Index. Absence of any evidence of intrahepatic or extrahepatic obstruction in these patients and the demonstration that splenectomy relieved portal hypertension defined at surgery in 4 patients, suggests that augmented adhepatic flow contributes to portal hypertension in some cases. The review leads to the conclusions that: 1) Operative procedures in prepared patients with myeloproliferative disorders are not associated with prohibitive mortality and morbidity rates. 2) Splenectomy is indicated for patients with increasing transfusion requirements and symptomatic splenomegaly or hypersplenism and should be performed early in the course of disease. 3) When associated portal hypertension and bleeding varices are present, hemodynamic studies should be carried out to define if splenectomy alone, or a portal systemic decompressive procedure is indicated.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BOURONCLE B. A., DOAN C. A. Myelofibrosis. Clinical, hematologic and pathologic study of 110 patients. Am J Med Sci. 1962 Jun;243:697–715. doi: 10.1097/00000441-196206000-00001. [DOI] [PubMed] [Google Scholar]
- CASSEL W. G., SPITTEL J. A., Jr, ELLIS F. H., Jr, BRUWER A. J. Arteriovenous fistula of the splenic vessels producing ascites. Circulation. 1957 Dec;16(6):1077–1083. doi: 10.1161/01.cir.16.6.1077. [DOI] [PubMed] [Google Scholar]
- Cardamone J. M., Edson J. R., McArthur J. R., Jacob H. S. Abnormalities of platelet function in the myeloproliferative disorders. JAMA. 1972 Jul 17;221(3):270–273. [PubMed] [Google Scholar]
- DAMESHEK W. Some speculations on the myeloproliferative syndromes. Blood. 1951 Apr;6(4):372–375. [PubMed] [Google Scholar]
- Dagradi A. E., Siemsen J., Brook J., Stempien S. J. Bleeding esophageal varices in myelofibrosis. Am J Gastroenterol. 1965 Dec;44(6):536–544. [PubMed] [Google Scholar]
- GREEN T. W., CONLEY C. L., ASHBURN L. L., PETERS H. R. Splenectomy for myeloid metaplasia of the spleen. N Engl J Med. 1953 Feb 5;248(6):211–219. doi: 10.1056/NEJM195302052480601. [DOI] [PubMed] [Google Scholar]
- JENSEN M. K. SPLENECTOMY IN MYELOFIBROSIS. Acta Med Scand. 1964 May;175:533–544. doi: 10.1111/j.0954-6820.1964.tb00605.x. [DOI] [PubMed] [Google Scholar]
- LEEVY C. M., GLIEDMAN M. L. Practical and research value of hepatic-vein catheterization. N Engl J Med. 1958 Apr 3;258(14):696–contd. doi: 10.1056/NEJM195804032581406. [DOI] [PubMed] [Google Scholar]
- Morgenstern L., Kahn F. H., Weinstein I. M. Subtotal splenectomy in myelofibrosis. Surgery. 1966 Aug;60(2):336–339. [PubMed] [Google Scholar]
- NEUBARDT S., SIEGMAN F. Hemorrhagic tendency in polycythemia vera. AMA Arch Surg. 1955 Feb;70(2):257–259. doi: 10.1001/archsurg.1955.01270080103017. [DOI] [PubMed] [Google Scholar]
- Neemeh J. A., Bowie E. J., Thompson J. H., Jr, Didisheim P., Owen C. A., Jr Quantitation of platelet aggregation in myeloproliferative disorders. Am J Clin Pathol. 1972 Mar;57(3):336–347. doi: 10.1093/ajcp/57.3.336. [DOI] [PubMed] [Google Scholar]
- Rosenbaum D. L., Murphy G. W., Swisher S. N. Hemodynamic studies of the portal circulation in myeloid metaplasia. Am J Med. 1966 Sep;41(3):360–368. doi: 10.1016/0002-9343(66)90081-7. [DOI] [PubMed] [Google Scholar]
- STENER B. Arterio-venous shunt in the spleen diagnosed before operation; case report. Acta Chir Scand. 1955 Jan 31;108(5):344–350. [PubMed] [Google Scholar]
- Sullivan A., Rheinlander H., Weintraub L. R. Esophageal varices in agnogenic myeloid metaplasia: disappearance after splenectomy. A case report. Gastroenterology. 1974 Mar;66(3):429–432. [PubMed] [Google Scholar]